CBAY logo

CymaBay Therapeutics (CBAY) Current Liabilities

CBAY Annual Current Liabilities

$36.84 M
+$21.40 M+138.61%

31 December 2023

CBAY Current Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CBAY Quarterly Current Liabilities

$36.84 M
+$17.18 M+87.34%

31 December 2023

CBAY Quarterly Current Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CBAY Current Liabilities Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+138.6%+87.3%
3 y3 years+273.8%+273.8%
5 y5 years+155.6%+155.6%

CBAY Current Liabilities High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year
5 y5-year
alltimeall timeat high-20.8%

CymaBay Therapeutics Current Liabilities History

DateAnnualQuarterly
Dec 2023
$36.84 M(+138.6%)
$36.84 M(+87.3%)
Sept 2023
-
$19.67 M(+9.9%)
June 2023
-
$17.89 M(-61.5%)
Mar 2023
-
$46.50 M(+201.1%)
Dec 2022
$15.44 M(-15.9%)
$15.44 M(+21.5%)
Sept 2022
-
$12.71 M(+1.2%)
June 2022
-
$12.56 M(-10.5%)
Mar 2022
-
$14.04 M(-23.6%)
Dec 2021
$18.37 M(+86.3%)
$18.37 M(+56.4%)
Sept 2021
-
$11.74 M(+31.1%)
June 2021
-
$8.96 M(+13.3%)
Mar 2021
-
$7.91 M(-19.8%)
Dec 2020
$9.86 M(-44.1%)
$9.86 M(-5.8%)
Sept 2020
-
$10.46 M(+10.4%)
June 2020
-
$9.48 M(-20.5%)
Mar 2020
-
$11.92 M(-32.4%)
Dec 2019
$17.64 M(+22.3%)
$17.64 M(+1.6%)
Sept 2019
-
$17.36 M(+12.6%)
June 2019
-
$15.42 M(+6.6%)
Mar 2019
-
$14.47 M(+0.4%)
Dec 2018
$14.41 M
$14.41 M(+5.7%)
DateAnnualQuarterly
Sept 2018
-
$13.64 M(-19.4%)
June 2018
-
$16.92 M(-5.6%)
Mar 2018
-
$17.92 M(+9.9%)
Dec 2017
$16.31 M(+75.2%)
$16.31 M(+16.3%)
Sept 2017
-
$14.03 M(+17.0%)
June 2017
-
$11.99 M(+11.2%)
Mar 2017
-
$10.78 M(+15.8%)
Dec 2016
$9.31 M(+51.5%)
$9.31 M(+20.1%)
Sept 2016
-
$7.75 M(+2.8%)
June 2016
-
$7.54 M(+11.8%)
Mar 2016
-
$6.75 M(+9.8%)
Dec 2015
$6.15 M(-70.0%)
$6.15 M(-0.1%)
Sept 2015
-
$6.15 M(-28.0%)
June 2015
-
$8.54 M(-37.5%)
Mar 2015
-
$13.66 M(-33.2%)
Dec 2014
$20.46 M(+115.6%)
$20.46 M(+36.1%)
Sept 2014
-
$15.03 M(+9.3%)
June 2014
-
$13.76 M(-11.4%)
Mar 2014
-
$15.52 M(+63.6%)
Dec 2013
$9.49 M(-47.1%)
$9.49 M
Dec 2012
$17.95 M
-

FAQ

  • What is CymaBay Therapeutics annual total current liabilities?
  • What is the all time high annual current liabilities for CymaBay Therapeutics?
  • What is CymaBay Therapeutics annual current liabilities year-on-year change?
  • What is CymaBay Therapeutics quarterly total current liabilities?
  • What is the all time high quarterly current liabilities for CymaBay Therapeutics?
  • What is CymaBay Therapeutics quarterly current liabilities year-on-year change?

What is CymaBay Therapeutics annual total current liabilities?

The current annual current liabilities of CBAY is $36.84 M

What is the all time high annual current liabilities for CymaBay Therapeutics?

CymaBay Therapeutics all-time high annual total current liabilities is $36.84 M

What is CymaBay Therapeutics annual current liabilities year-on-year change?

Over the past year, CBAY annual total current liabilities has changed by +$21.40 M (+138.61%)

What is CymaBay Therapeutics quarterly total current liabilities?

The current quarterly current liabilities of CBAY is $36.84 M

What is the all time high quarterly current liabilities for CymaBay Therapeutics?

CymaBay Therapeutics all-time high quarterly total current liabilities is $46.50 M

What is CymaBay Therapeutics quarterly current liabilities year-on-year change?

Over the past year, CBAY quarterly total current liabilities has changed by +$17.18 M (+87.34%)